(Q34163587)

English

Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors

scientific article

Statements

Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors (English)
Federico Caligaris-Cappio

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit